Metabolic Profiling of a Corynebacterium glutamicum ΔprpD2 by GC-APCI High Resolution Q-TOF Analysisimpact

Significance of Metabolic Profiling by GC-APCI High-Resolution Q-TOF

Metabolic profiling of microorganisms provides critical insights into cellular responses and pathway fluxes under varying conditions. The use of gas chromatography coupled to high‐resolution mass spectrometry via an atmospheric pressure chemical ionization source enables detection and identification of a broader range of metabolites, including those lacking reference spectra in classical libraries. This approach enhances biomarker discovery and supports industrial and research applications in microbial biotechnology.

Aims and Study Overview

This study investigates the metabolic response of a Corynebacterium glutamicum ΔprpD2 mutant to a propionate pulse during exponential growth on glucose. Key objectives were:

• To apply GC-APCI-micrOTOF-Q II technology for untargeted profiling of intracellular metabolites.
• To differentiate metabolic fingerprints before and after propionate addition.
• To identify accumulated compounds using accurate mass and isotopic pattern information.

Methodology

Cultures of C. glutamicum ΔprpD2 were grown in biological duplicates on glucose and subjected to a propionate pulse at OD600 = 3. Two technical replicates were harvested before and one hour after the pulse. Dried methanolic extracts were derivatized by methoximation and trimethylsilylation. Samples were analyzed on a GC-APCI interface linked to a micrOTOF-Q II. Data acquisition ranged from 85 to 750 m/z at four spectra per second. Raw data were recalibrated, and molecular features were extracted using the Find Molecular Features algorithm in ProfileAnalysis 2.0. Feature intensities were normalized to ribitol. Principal Component Analysis (PCA) distinguished sample groups. SmartFormula and SmartFormula3D tools generated sum formula candidates from MS and MS/MS spectra. CompoundCrawler was used for database queries.

Instrumentation

• Gas chromatograph with HP-5MS column (30 m × 0.25 mm × 0.25 µm)
• Bruker GC-APCI source
• micrOTOF-Q II high-resolution Q-TOF mass spectrometer
• ProfileAnalysis 2.0 for data processing
• SmartFormula3D for sum formula generation
• CompoundCrawler for database search

Main Results and Discussion

PCA scores revealed clear clustering of extracts according to carbon source and propionate treatment. Two key metabolites driving group separation were:

• 2-Methylcitrate (retention 27.2 min, m/z 495.21): SmartFormula3D reduced candidate formulas to C19H43O7Si4. Fragment and neutral loss patterns matched the trimethylsilylated derivative. Accumulation confirmed by comparison with a standard.
• Alanine derivative (retention 9.3 min, m/z 234.13): Sum formula C9H24N1O2Si2 corresponded to N-(trimethylsilyl)alaninate. MS/MS fragmentation and database query supported this annotation.

This workflow demonstrates the advantage of soft APCI ionization to preserve molecular ions, enabling reliable sum formula generation and structural elucidation of previously unidentifiable biomarkers.

Practical Benefits and Applications

• Improved identification of metabolites lacking reference EI spectra.
• Rapid switching between LC and GC modes on the same instrument.
• Enhanced structural insights through simultaneous MS and MS/MS acquisition.
• Applicability to microbial metabolic engineering, quality control, and pathway analysis.

Future Trends and Applications

Integration of GC-APCI high-resolution MS with automated data analysis and expanded spectral databases will further accelerate biomarker discovery. Combining this approach with other omics platforms, machine learning–driven annotation, and improved derivatization strategies promises deeper coverage of the metabolome and real-time process monitoring in bioprocess industries.

Conclusion

GC-APCI-micrOTOF-Q II profiling of C. glutamicum ΔprpD2 successfully differentiated metabolic states before and after a propionate pulse. High-resolution accurate mass and isotopic pattern analysis enabled unambiguous identification of 2-methylcitrate and a trimethylsilylated alanine derivative. This strategy overcomes limitations of conventional GC-EI-MS and provides a robust platform for comprehensive metabolomics.

References

1. Bruker Daltonics Technical Note TN-23: Certainty in Small Molecule Identification by Applying SmartFormula3D on an UHR-TOF Mass Spectrometer.
2. J. Plassmeier et al. Journal of Biotechnology 130 (2007) 354–363.